Insmed (INSM) Accounts Payables (2010 - 2026)

Insmed's Accounts Payables history runs 17 years deep, the most recent figure standing at $352.6 million for Q1 2026.

• In Q1 2026, Accounts Payables rose 51.52% year-over-year to $352.6 million; the TTM figure through Mar 2026 stood at $352.6 million (up 51.52% YoY), while the FY2025 annual figure was $456.1 million, up 59.9% from the prior year.
• Accounts Payables for Q1 2026 stood at $352.6 million, down from $456.1 million in the prior quarter.
• The five-year high for Accounts Payables was $456.1 million in Q4 2025, with the low at $31.1 million in Q2 2022.
• The 5-year median for Accounts Payables is $258.9 million (2024), against an average of $251.8 million.
• Peak annual rise in Accounts Payables reached 116.62% in 2022, while the deepest fall reached 0.2% in 2022.
• Insmed's Accounts Payables stood at $182.1 million in 2022, then gained by 18.05% to $215.0 million in 2023, then surged by 32.66% to $285.2 million in 2024, then jumped by 59.9% to $456.1 million in 2025, then fell by 22.7% to $352.6 million in 2026.
• Business Quant data shows INSM's Accounts Payables at $352.6 million in Q1 2026, $456.1 million in Q4 2025, and $409.8 million in Q3 2025.